First Trust Advisors
CELL

First Trust Advisors’s PhenomeX Inc. Common Stock CELL Stock Holding History

First Trust Advisors’s Portfolio CELL Stock Details CELL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-22,148
Closed -$157K – 2644
2022
Q1 		$157K Buy
+22,148
New +$183K ﹤0.01% 2488

Other funds holding CELL

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

First Trust Advisors's CELL Position: Q2 2022 in Review

First Trust Advisors sold out of PhenomeX Inc. Common Stock (CELL) in Q2 2022, closing a stake of 22,148 shares — an estimated $157K sold.

First Trust Advisors first reported a position in CELL in Q1 2022 and held it in 1 quarter. The position peaked at $157K in Q1 2022. 123 funds tracked by Wall St. Rank hold CELL as of Q2 2022.

  • First Trust Advisors reported no remaining PhenomeX Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • First Trust Advisors sold 22,148 PhenomeX Inc. Common Stock shares in Q2 2022, an estimated $157K.
  • First Trust Advisors first reported a position in PhenomeX Inc. Common Stock in Q1 2022 and held it in 1 quarter.
  • First Trust Advisors's PhenomeX Inc. Common Stock position peaked at $157K in Q1 2022.
  • 123 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q2 2022.

Based on First Trust Advisors's 13F filing for Q2 2022, filed 12 Aug 2022.